US Stock MarketDetailed Quotes

XBIO Xenetic Biosciences

Watchlist
  • 3.3507
  • -0.0293-0.87%
Trading Mar 25 09:31 ET
5.17MMarket Cap-1.30P/E (TTM)

Xenetic Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-1.56%2.5M
-3.44%648.82K
0.50%614.24K
11.58%726.4K
-15.69%510.82K
48.80%2.54M
37.99%671.96K
47.54%611.17K
56.22%651.01K
55.75%605.84K
Operating revenue
-1.56%2.5M
-3.44%648.82K
0.50%614.24K
11.58%726.4K
-15.69%510.82K
48.80%2.54M
37.99%671.96K
47.54%611.17K
56.22%651.01K
55.75%605.84K
Cost of revenue
Gross profit
Operating expense
-4.97%6.7M
-9.32%1.75M
-36.64%1.11M
11.61%2.06M
16.98%1.78M
-16.25%7.06M
-5.98%1.93M
39.29%1.76M
-40.42%1.85M
-24.28%1.52M
Selling and administrative expenses
-4.06%3.42M
-25.87%705.71K
1.15%745.73K
19.46%1.13M
-9.81%834.91K
-2.55%3.56M
11.06%952K
-14.60%737.24K
-7.83%945.95K
2.03%925.74K
-General and administrative expense
-4.06%3.42M
-25.87%705.71K
1.15%745.73K
19.46%1.13M
-9.81%834.91K
-2.55%3.56M
11.06%952K
-14.60%737.24K
-7.83%945.95K
2.03%925.74K
Research and development costs
-5.91%3.29M
6.83%1.04M
-63.94%367.99K
3.38%933.77K
58.64%944.32K
-26.75%3.49M
-18.23%975.63K
155.92%1.02M
-56.52%903.24K
-45.95%595.28K
Operating profit
6.89%-4.2M
12.47%-1.1M
56.44%-499.47K
-11.62%-1.34M
-38.60%-1.27M
32.78%-4.52M
19.68%-1.26M
-35.26%-1.15M
55.41%-1.2M
43.50%-915.18K
Net non-operating interest income expense
-29.77%249.86K
-38.07%51.87K
-33.22%61.3K
-49.69%63.45K
35.39%73.25K
112.83%355.76K
4.95%83.76K
101.86%91.8K
689.87%126.1K
108.84%54.1K
Non-operating interest income
-29.77%249.86K
-38.07%51.87K
-33.22%61.3K
-49.69%63.45K
35.39%73.25K
112.83%355.76K
4.95%83.76K
101.86%91.8K
689.87%126.1K
108.84%54.1K
Other net income (expense)
-122.49%-5.71K
-1,892.82%-7.24K
325.83%1.5K
-100.10%-21
-98.85%52
1,689.23%25.38K
-59.03%404
60.96%-666
2,063.01%21.12K
2,171.36%4.52K
Other non- operating income (expenses)
-122.49%-5.71K
-1,892.82%-7.24K
325.83%1.5K
-100.10%-21
-98.85%52
1,689.23%25.38K
-59.03%404
60.96%-666
2,063.01%21.12K
2,171.36%4.52K
Income before tax
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
Income tax
Net income
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
Net income continuous Operations
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
Minority interest income
Net income attributable to the parent company
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
Basic earnings per share
5.17%-2.57
11.69%-0.68
59.42%-0.28
-20.29%-0.83
-39.29%-0.78
41.21%-2.71
20.62%-0.77
-23.21%-0.69
63.68%-0.69
53.33%-0.56
Diluted earnings per share
5.17%-2.57
11.69%-0.68
59.42%-0.28
-20.29%-0.83
-39.29%-0.78
41.21%-2.71
20.62%-0.77
-23.21%-0.69
63.68%-0.69
53.33%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -1.56%2.5M-3.44%648.82K0.50%614.24K11.58%726.4K-15.69%510.82K48.80%2.54M37.99%671.96K47.54%611.17K56.22%651.01K55.75%605.84K
Operating revenue -1.56%2.5M-3.44%648.82K0.50%614.24K11.58%726.4K-15.69%510.82K48.80%2.54M37.99%671.96K47.54%611.17K56.22%651.01K55.75%605.84K
Cost of revenue
Gross profit
Operating expense -4.97%6.7M-9.32%1.75M-36.64%1.11M11.61%2.06M16.98%1.78M-16.25%7.06M-5.98%1.93M39.29%1.76M-40.42%1.85M-24.28%1.52M
Selling and administrative expenses -4.06%3.42M-25.87%705.71K1.15%745.73K19.46%1.13M-9.81%834.91K-2.55%3.56M11.06%952K-14.60%737.24K-7.83%945.95K2.03%925.74K
-General and administrative expense -4.06%3.42M-25.87%705.71K1.15%745.73K19.46%1.13M-9.81%834.91K-2.55%3.56M11.06%952K-14.60%737.24K-7.83%945.95K2.03%925.74K
Research and development costs -5.91%3.29M6.83%1.04M-63.94%367.99K3.38%933.77K58.64%944.32K-26.75%3.49M-18.23%975.63K155.92%1.02M-56.52%903.24K-45.95%595.28K
Operating profit 6.89%-4.2M12.47%-1.1M56.44%-499.47K-11.62%-1.34M-38.60%-1.27M32.78%-4.52M19.68%-1.26M-35.26%-1.15M55.41%-1.2M43.50%-915.18K
Net non-operating interest income expense -29.77%249.86K-38.07%51.87K-33.22%61.3K-49.69%63.45K35.39%73.25K112.83%355.76K4.95%83.76K101.86%91.8K689.87%126.1K108.84%54.1K
Non-operating interest income -29.77%249.86K-38.07%51.87K-33.22%61.3K-49.69%63.45K35.39%73.25K112.83%355.76K4.95%83.76K101.86%91.8K689.87%126.1K108.84%54.1K
Other net income (expense) -122.49%-5.71K-1,892.82%-7.24K325.83%1.5K-100.10%-21-98.85%521,689.23%25.38K-59.03%40460.96%-6662,063.01%21.12K2,171.36%4.52K
Other non- operating income (expenses) -122.49%-5.71K-1,892.82%-7.24K325.83%1.5K-100.10%-21-98.85%521,689.23%25.38K-59.03%40460.96%-6662,063.01%21.12K2,171.36%4.52K
Income before tax 4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K
Income tax
Net income 4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K
Net income continuous Operations 4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K
Minority interest income
Net income attributable to the parent company 4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K
Basic earnings per share 5.17%-2.5711.69%-0.6859.42%-0.28-20.29%-0.83-39.29%-0.7841.21%-2.7120.62%-0.77-23.21%-0.6963.68%-0.6953.33%-0.56
Diluted earnings per share 5.17%-2.5711.69%-0.6859.42%-0.28-20.29%-0.83-39.29%-0.7841.21%-2.7120.62%-0.77-23.21%-0.6963.68%-0.6953.33%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Wintech Nano
688757
+202.42%
CHANGFU CO.,LTD
871396
+29.97%
DIER CHEMICAL
831304
+27.61%
4
CHENGUANG MEDICAL
430300
+21.92%
5
TLC
873576
+20.34%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
Earnings Season Underway
Earnings season is here. What to know?